Pharma Global News Today

The announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Fridays closing price. Strides Pharma Science shares also hit their 52-week high of Rs 539.

PT Kalbe Farma Tbk and PT Amarox Global Pharma announced that they have begun marketing Movfor (Molnupiravir), the newest antiviral drug for COVID-19, in ...

Amarox is expected to kick off the domestic production of Molnupiravir in April or May 2022.

Indonesia is targeting to start local production of two COVID-19 antiviral pills, Molnupiravir and Paxlovid, in April or May this year...

Thailand's health minister said on Friday night (Jan 14) the country planned to develop the antiviral pill molnupiravir to combat Covid-19 cases amid rising infections driven by the Omicron variant.

BANGKOK: Public Health Minister Anutin Charnvirakul has announced that Thailand will move ahead with its plans to develop the COVID-19 antiviral pill molnupiravir.

BANGKOK/JAKARTA - Thailand's health minister said on Friday (Jan 14) the country planned to develop the antiviral pill molnupiravir to combat Covid-19 cases amid rising infections driven by the Omicron variant. The molnupiravir Covid-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by US-based Merck and Ridgeback Biotherapeutics. The South-east Asian nation intends to...

Thailand intends to join others in the region also planning to make versions of the drug like Bangladesh and India. . Read more at straitstimes.com.

Thailand's Public Health Minister Anutin Charnvirakul said on Friday the country planned to develop the anti-viral pill molnupiravir to combat Covid-19 infections amid rising infections driven by the Omicron coronavirus variant.

Thailand's Public Health Minister Anutin Charnvirakul said on Friday the country planned to develop the anti-viral pill molnupiravir to combat Covid-19 infections amid rising infections driven by the Omicron coronavirus variant.